Stockreport

Lexaria releases additional results from Phase 1b study GLP-1-H24-4 [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF chronic study GLP-1-H24-4, recently completed in Australia, focusing on 4 DehydraTECH study arms relative to the Rybelsus control study arm. At week 16, rough parity was [Read more]